Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

被引：0
|
作者：
Nikolaos Thomakos
Alexandros Rodolakis
Flora Zagouri
Dimitrios Zacharakis
Maria Sotiropoulou
Nikolaos Akrivos
Dimitrios Haidopoulos
Christos A. Papadimitriou
Meletios-Athanassios Dimopoulos
Aris Antsaklis
机构：
[1] University of Athens,Department of Obstetrics and Gynecology, Alexandra Hospital, School of Medicine
[2] University of Athens,Department of Clinical and Therapeutics, Alexandra Hospital, School of Medicine
[3] Alexandra Hospital,Department of Pathology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 287卷
关键词：
CEA; CA 125; CA 19-9; CA 15-3; Serum; Uterine carcinosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 102
页数：5
相关论文
共 50 条
  • [1] Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
    Thomakos, Nikolaos
    Rodolakis, Alexandros
    Zagouri, Flora
    Zacharakis, Dimitrios
    Sotiropoulou, Maria
    Akrivos, Nikolaos
    Haidopoulos, Dimitrios
    Papadimitriou, Christos A.
    Dimopoulos, Meletios-Athanassios
    Antsaklis, Aris
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (01) : 97 - 102
  • [2] Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study
    Ercan, Serif
    Kaymaz, Ozge
    Yucel, Nihal
    Orcun, Asuman
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (03) : 579 - 584
  • [3] Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study
    Şerif Ercan
    Özge Kaymaz
    Nihal Yücel
    Asuman Orçun
    Archives of Gynecology and Obstetrics, 2012, 285 : 579 - 584
  • [4] EFFICACY OF CARBOHYDRATE ANTIGENS (CA 19-9, CA 125, CA 15-3) FOR DIAGNOSIS AND PROGNOSTIC FACTORS OF BLADDER TUMOR
    Kosan, Murat
    Tul, Mesut
    Gonulalan, Umut
    Ugurlu, Ozgur
    Inal, Gurdal
    Adsan, Oztug
    TURKISH JOURNAL OF UROLOGY, 2008, 34 (02): : 155 - 160
  • [5] Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy women
    Erbagci, AB
    Yilmaz, N
    Kutlar, I
    DISEASE MARKERS, 1999, 15 (04) : 259 - 267
  • [6] Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125
    Kremser, Marcel
    Weiss, Nathalie
    Kaufmann-Stoeck, Anne
    Vierbaum, Laura
    Schmitz, Arthur
    Schellenberg, Ingo
    Holdenrieder, Stefan
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [7] Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
    Lee, Kyong Joo
    Yi, Seung Woo
    Chung, Moon Jae
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bock
    Park, Jeong Youp
    YONSEI MEDICAL JOURNAL, 2013, 54 (03) : 643 - 649
  • [8] Maternal serum CA 19-9 and CA 15-3 levels in pregnancies affected by trisomy 21
    Akinlade, F.
    Cowans, N. J.
    Kisanga, M. C.
    Spencer, K.
    PRENATAL DIAGNOSIS, 2012, 32 (07) : 644 - 648
  • [9] Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
    Wang, Wei
    Chen, Xiao-Long
    Zhao, Shen-Yu
    Xu, Yu-Hui
    Zhang, Wei-Han
    Liu, Kai
    Chen, Xin-Zu
    Yang, Kun
    Zhang, Bo
    Chen, Zhi-Xin
    Chen, Jia-Ping
    Zhou, Zong-Guang
    Hu, Jian-Kun
    ONCOTARGET, 2016, 7 (23) : 35423 - 35436
  • [10] Treatment of Ruptured Ovarian Endometrioma with Extremely High CA 125, Moderately High CA 19-9 and CA 15-3 Level
    Duran, Muzeyyen
    Kosus, Aydin
    Kosus, Nermin
    Duvam, Candan
    Kafali, Hasan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2013, 4 : 299 - 301
12345